Golden State Equity Partners Has $396,000 Stock Position in American Healthcare REIT, Inc. (NYSE:AHR)

Golden State Equity Partners reduced its stake in American Healthcare REIT, Inc. (NYSE:AHR) by 7.5% during the 1st quarter, Holdings Channel reports. The firm owned 13,082 shares of the company’s stock after selling 1,063 shares during the period. Golden State Equity Partners’ holdings in American Healthcare REIT were worth $396,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the stock. Truist Financial Corp grew its holdings in American Healthcare REIT by 16.5% during the fourth quarter. Truist Financial Corp now owns 14,229 shares of the company’s stock valued at $404,000 after purchasing an additional 2,019 shares during the period. New York State Common Retirement Fund grew its holdings in shares of American Healthcare REIT by 58.6% in the 4th quarter. New York State Common Retirement Fund now owns 34,100 shares of the company’s stock valued at $969,000 after buying an additional 12,600 shares during the period. Handelsbanken Fonder AB bought a new stake in shares of American Healthcare REIT in the 4th quarter valued at $1,103,000. IFP Advisors Inc increased its position in shares of American Healthcare REIT by 14.4% in the 4th quarter. IFP Advisors Inc now owns 4,683 shares of the company’s stock valued at $134,000 after buying an additional 591 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its stake in American Healthcare REIT by 139.7% during the 4th quarter. Bank of New York Mellon Corp now owns 728,853 shares of the company’s stock worth $20,714,000 after buying an additional 424,773 shares during the period. 16.68% of the stock is owned by institutional investors and hedge funds.

American Healthcare REIT Trading Down 0.1%

NYSE:AHR opened at $36.12 on Friday. The company has a market cap of $5.76 billion, a P/E ratio of -133.79, a price-to-earnings-growth ratio of 2.03 and a beta of 1.21. American Healthcare REIT, Inc. has a twelve month low of $14.35 and a twelve month high of $36.96. The business has a 50 day moving average price of $33.97 and a two-hundred day moving average price of $30.55. The company has a quick ratio of 0.38, a current ratio of 0.38 and a debt-to-equity ratio of 0.45.

American Healthcare REIT (NYSE:AHR) last announced its earnings results on Thursday, May 8th. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.37 by $0.01. The business had revenue of $540.60 million during the quarter, compared to analysts’ expectations of $542.32 million. American Healthcare REIT had a negative net margin of 1.96% and a negative return on equity of 1.85%. The firm’s revenue was up 8.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.30 earnings per share. As a group, analysts expect that American Healthcare REIT, Inc. will post 1.41 EPS for the current fiscal year.

American Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 18th. Stockholders of record on Monday, June 30th will be paid a dividend of $0.25 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.77%. American Healthcare REIT’s dividend payout ratio is -370.37%.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on AHR shares. KeyCorp boosted their target price on American Healthcare REIT from $34.00 to $40.00 and gave the company an “overweight” rating in a research note on Wednesday, June 11th. Morgan Stanley boosted their price objective on American Healthcare REIT from $37.00 to $45.00 and gave the company an “overweight” rating in a research report on Tuesday, May 20th. Jefferies Financial Group assumed coverage on shares of American Healthcare REIT in a report on Monday, April 28th. They set a “buy” rating and a $37.00 target price on the stock. Truist Financial upped their price target on shares of American Healthcare REIT from $32.00 to $38.00 and gave the company a “buy” rating in a report on Monday, June 9th. Finally, JMP Securities set a $35.00 price objective on shares of American Healthcare REIT in a research report on Tuesday, March 4th. Eight analysts have rated the stock with a buy rating, According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $37.14.

American Healthcare REIT Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.